Establishment Labs Holdings Inc. (ESTA)
Automate Your Wheel Strategy on ESTA
With Tiblio's Option Bot, you can configure your own wheel strategy including ESTA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ESTA
- Rev/Share 5.7754
- Book/Share 1.3079
- PB 29.0781
- Debt/Equity 0.0987
- CurrentRatio 3.3561
- ROIC -0.2164
- MktCap 1099724919.0
- FreeCF/Share -2.3588
- PFCF -15.8174
- PE -12.5803
- Debt/Assets 0.0114
- DivYield 0
- ROE -2.1043
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | ESTA | BTIG Research | -- | Buy | -- | $62 | May 16, 2025 |
| Upgrade | ESTA | Needham | Hold | Buy | -- | $48 | May 14, 2025 |
| Initiation | ESTA | Needham | -- | Hold | -- | -- | April 14, 2025 |
News
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Lags Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.70 per share versus the Zacks Consensus Estimate of a loss of $0.83. This compares to loss of $0.58 per share a year ago.
Read More
Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants®
Published: March 06, 2025 by: PRNewsWire
Sentiment: Neutral
The campaign is the first-of-its-kind partnership and follows the US FDA approval of Motiva Implants® NEW YORK , March 6, 2025 /PRNewswire/ -- Establishment Labs® Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a partnership with GRAMMY Award-winning hitmaker Meghan Trainor. Meghan recently received Motiva Implants® after careful consideration and research.
Read More
Establishment Labs Holdings Inc. (ESTA) Q4 2024 Earnings Call Transcript
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral
Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Raj Denhoy - CFO Juan Chacón-Quirós - CEO Peter Caldini - President Conference Call Participants Anthony Petrone - Mizuho Group Allen Gong - JPMorgan Josh Jennings - TD Cowen Marie Thibault - BTIG Joanne Wuensch - Citibank Matt Taylor - Jefferies Harrison Parsons - Stephens Inc Operator Good afternoon. Welcome to Establishment Labs Fourth Quarter 2024 Earnings Call.
Read More
Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26
Published: February 14, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended December 31, 2024, after the market closes on Wednesday, February 26, 2025, and will host a conference call at 4:30 pm ET that day to discuss those results. To participate in the conference call, dial (877) 407-8037 (U.S.
Read More
About Establishment Labs Holdings Inc. (ESTA)
- IPO Date 2018-07-19
- Website https://www.establishmentlabs.com
- Industry Medical - Devices
- CEO Mr. Fillipo Peter Caldini
- Employees 1034